Gilead Sciences Inc

NASDAQ : GILD

Industry : Biotechnology | ISIN : US3755581036 | FreeFloat : 99.90% | FnO : Yes | LotSize : 100


Intellectual Capital (IC)168,023.50
Net Worth (NW)21,081.00
Intrinsic Worth (IW)189,104.50
Market Cap (MC)77,791.09
Economic Value Added1,463.40
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)88.85%
IC Gross Margin (EBITDA/IC)4.66%
IC Net Margin (NPT/IC)3.02%
Knowledge Turnover (Sales/IC)0.17
Market to Intrinsic Value (MC/IW)0.41

As OfIntrinsic ValueMarket Price
Sep 30 2022$ 149.96$ 61.69
Jan 26 2023 ---- $ 83.62
-0.45     -0.54%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : $ 84.24SellAvoid
KB > 50% : Yes50 DMA : $ 85.75
0 < M2IV < 1 : YesVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results ($ Mn)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
5879.00
6930.00
2494.00
2144.00
1901.00
2696.00
2703.00
Mar-20
C
5548.00
5390.00
2244.00
2244.00
2003.00
1551.00
1564.00
Jun-20
C
5143.00
869.00
-2384.00
-2733.00
-2973.00
-3339.00
-3332.00
Sep-20
C
6577.00
5637.00
1416.00
1061.00
825.00
353.00
360.00
Dec-20
C
7421.00
6787.00
2508.00
2081.00
1814.00
1544.00
1551.00
Mar-21
C
6423.00
5992.00
2994.00
2521.00
2264.00
1722.00
1729.00
Jun-21
C
6217.00
5948.00
2073.00
2073.00
1817.00
1517.00
1522.00
Sep-21
C
7421.00
7248.00
4211.00
3688.00
3438.00
2586.00
2592.00
Dec-21
C
7244.00
7244.00
1236.00
997.00
759.00
376.00
382.00
Mar-22
C
6590.00
6590.00
166.00
86.00
-152.00
12.00
19.00
Jun-22
C
6260.00
6260.00
1905.00
1745.00
1503.00
1135.00
1144.00
Sep-22
C
7042.00
7042.00
1851.00
2661.00
2432.00
1786.00
1789.00
* C - Consolidated, S - Standalone